Ketamine-Assisted Psychotherapy (KAP) is a short term, intensive treatment for treatment-resistant Depression, Anxiety, PTSD, and Bipolar Depression. Our standard KAP protocol is based on research outcomes and typically consists of two 90 minute sessions/week for 4 weeks. Following completion of the intensive protocol, individualized maintenance plans are available to support your continued optimal functioning into the future.
The first step is to schedule an intake appointment at our North Hollywood office with one of our ketamine-assisted therapy pairs. All of our treatment teams consist of one licensed medical and one mental health professional, both authorized by their respective licensure boards to provide the gold standard of professional psychiatric and psychotherapeutic services. Visit our appointments page to schedule an intake.
Are you experiencing traumatic stress, depression, anxiety, suicidal thoughts, spiritual, or relationship challenges? Have you struggled to feel change despite prior attempts at therapy? Interested in understanding your inner self, your purpose and how that impacts your behavior? Depth-oriented, transpersonal psychotherapy sessions can support you in developing balanced self-awareness and healthy communication skills. Together with one of our psychotherapists, you can increase your insight, emotional intelligence, and upgrade your interactions with daily life and relationships in a supportive and confidential space. All of our psychotherapists have graduate degrees focused on clinical psychotherapy and post-graduate training and supervision in transpersonal, depth-oriented therapy. See our team’s bios for additional specializations and certifications. We work with you to co-create the change you want to see in your life.
Talk therapy sessions are typically one 50 minute session/week one-on-one with a board registered mental health professional. The duration of treatment is individually determined based on your intake evaluation, current symptoms and treatment goals. CCPT offers sliding scale appointments for talk therapy for those who can demonstrate financial need.
Psychedelic Integration Therapy
Psychedelic Integration Therapy is designed to support the synthesis of the mind and body following the experience of a non-ordinary state of consciousness prompted by ingestion of psychedelics. Though psychedelic experiences are highly regulated within the US, many people continue to seek out psychedelics within certain clinical, religious, or spiritual settings with hopes of broadening their minds, changing their behaviors, and relationships or sometimes, simply having fun. Our integration services offer a safe, confidential space to process, explore, and share challenges and insights into non-ordinary states and the potential for personal transformation that they offer. Integration services often include somatic, mindfulness, art, and talk interventions, as well as a harm reduction approach to support increased education and safety in the psychedelic process.
We do not provide, condone or support the use of illegal substances or any other illegal activities. Psychedelics are not inherently healing outside of therapeutic or ceremonial settings and serious negative consequences have been well documented from illegal, recreational use of these substances. Collaboration with experienced and qualified medical and/or religious professionals is the best way to minimize the inherent risks in using psychedelics.
Integration plans can be as simple as a one time appointment to process a single experience or more complex, individualized plan determined by your particular needs.
Emerging Evidence for other Psychedelic-Assisted Therapies
MDMA-Assisted Psychotherapy for PTSD
MDMA-Assisted psychotherapy is currently available to a limited amount of people with PTSD who qualify for participation in FDA phase III clinical trials and has been designated as a Breakthrough Therapy by the FDA. Our staff includes multiple members of the Los Angeles phase II and III clinical team, who have been offering MDMA-Assisted Psychotherapy through the trials since early 2018. Additionally, we are in the processes of being approved as an Expanded Access site to offer the treatment to qualified people with PTSD outside of the clinical trials, likely sometime in 2020, due to the efficacy of the treatments during the prior phases of the clinical trials. Once this treatment is given final approval by FDA, we will be uniquely positioned and qualified to immediately offer this treatment clinically to a range of people in need.
Additionally, MDMA-Assisted Psychotherapy has shown promise through completed phase II clinical trials for Social Anxiety in Autistic Adults. MDMA-Assisted Psychotherapy for Anxiety Associated with Life Threatening Illness has also completed phase II clinical trials, though the results have not yet been published.
Psilocybin-Assisted Psychotherapy for Treatment Resistant Depression
Psilocybin-Assisted psychotherapy is currently in FDA phase II clinical trials and has been designated as a Breakthrough Therapy by the FDA. Additionally, research has been conducted at top research institutions such as UCLA, NYU, and Johns Hopkins University showing promise of Psilocybin-Assisted Psychotherapy for various conditions such as smoking cessation and end of life anxiety. CCPT intends to offer this valuable treatment as soon as it becomes available, rounding out our psychedelic-assisted psychotherapy offerings to include Ketamine-, MDMA- and Psilocybin-Assisted Psychotherapies.